IL153241A0 - Powder compositions - Google Patents

Powder compositions

Info

Publication number
IL153241A0
IL153241A0 IL15324101A IL15324101A IL153241A0 IL 153241 A0 IL153241 A0 IL 153241A0 IL 15324101 A IL15324101 A IL 15324101A IL 15324101 A IL15324101 A IL 15324101A IL 153241 A0 IL153241 A0 IL 153241A0
Authority
IL
Israel
Prior art keywords
powder compositions
compositions
powder
Prior art date
Application number
IL15324101A
Other languages
English (en)
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Publication of IL153241A0 publication Critical patent/IL153241A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
IL15324101A 2000-06-08 2001-06-08 Powder compositions IL153241A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59077700A 2000-06-08 2000-06-08
US21058100P 2000-06-08 2000-06-08
PCT/US2001/018494 WO2001093829A2 (en) 2000-06-08 2001-06-08 Powder compositions

Publications (1)

Publication Number Publication Date
IL153241A0 true IL153241A0 (en) 2003-07-06

Family

ID=26905296

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15324101A IL153241A0 (en) 2000-06-08 2001-06-08 Powder compositions

Country Status (11)

Country Link
EP (1) EP1289494A2 (de)
JP (1) JP2003535119A (de)
KR (1) KR20030020294A (de)
CN (1) CN1438874A (de)
AU (1) AU2001275371B9 (de)
BR (1) BR0111494A (de)
CA (1) CA2412197A1 (de)
IL (1) IL153241A0 (de)
MX (1) MXPA02012039A (de)
NZ (2) NZ552576A (de)
WO (1) WO2001093829A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2449593A1 (en) * 2001-06-08 2002-12-19 Powderject Vaccines, Inc. Spray freeze-dried compositions
CN1607941A (zh) * 2001-11-19 2005-04-20 贝克顿迪肯森公司 粒状药物组合物
US7923029B2 (en) 2002-04-11 2011-04-12 Medimmune Llc Spray freeze dry of compositions for pulmonary administration
DE10339197A1 (de) * 2003-08-22 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
TW200626177A (en) * 2004-09-28 2006-08-01 Alza Corp Method and formulation for stabilizing alum-adsorbed vaccines
EP1904290A4 (de) * 2005-06-27 2013-12-18 Applied Thin Films Inc Mikrokügelchen auf aluminiumphosphatbasis
EP1933867A1 (de) 2005-10-04 2008-06-25 Alk-Abello A/S Feste impfstoff-formulierung
EP1945249A2 (de) * 2005-11-01 2008-07-23 Novartis AG Zusammensetzungen mit an calciumphosphat adsorbierten antigenen
US20080226729A1 (en) * 2006-09-08 2008-09-18 Becton, Dickinson And Company Stable powder formulations of alum-adsorbed vaccines
JP2010505883A (ja) 2006-10-12 2010-02-25 ザ ユニバーシティー オブ クイーンズランド 免疫応答を調節するための組成物および方法
CA2681567C (en) 2007-03-22 2016-07-19 The Regents Of The University Of Colorado, A Body Corporate Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
MX2010001054A (es) * 2007-07-26 2010-04-21 Sanofi Pasteur Ltd Composiciones adyuvantes antigenicas y metodos.
ES2615390T3 (es) 2008-03-05 2017-06-06 Sanofi Pasteur Proceso para estabilizar una composición de vacuna que contiene adyuvante
AU2009299615B2 (en) 2008-10-02 2015-07-16 Pharmathene Inc. Anthrax vaccine formulation and uses thereof
BR112012025047A2 (pt) 2010-03-31 2016-06-21 Stabilitech Ltd formulações líquidas estabilizadas
EP2552410B1 (de) * 2010-03-31 2018-10-24 Stabilitech Biopharma Ltd Verfahren zur konservierung von alaun-adjuvantien und imfpstoffe mit alaun-adjuvantien
HUE026885T2 (en) 2010-03-31 2016-08-29 Stabilitech Ltd Stabilize virus fragments
BR112013010926A2 (pt) 2010-11-01 2016-08-23 Univ Technology Sidney agentes imunomoduladores e seus usos
MX349294B (es) 2010-12-02 2017-07-21 Oncolytics Biotech Inc Formulaciones virales liofilizadas.
AU2011336413B2 (en) 2010-12-02 2015-01-22 Oncolytics Biotech Inc. Liquid viral formulations
CN102133396B (zh) * 2011-03-16 2013-10-16 中国人民解放军第三〇二医院 一种疫苗注射剂及其制备方法
US12447127B2 (en) 2011-05-17 2025-10-21 The Regents Of The University Of Colorado, A Body Corporate Thermostable vaccine compositions and methods of preparing the same
US20130309273A1 (en) 2012-05-17 2013-11-21 Kimberly Hassett Thermostable Vaccine Compositions and Methods of Preparing Same
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
WO2013133702A1 (en) * 2012-03-05 2013-09-12 De Staat Der Nederlanden, Vert. Door De Minister Van Vws Methods and compositions for stabilizing dried biological materials
KR101441539B1 (ko) * 2013-04-01 2014-09-18 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 흡습성이 개선된 접착제 조성물 및 이의 제조방법
CN103641886B (zh) * 2013-11-26 2015-07-29 精晶药业股份有限公司 一种丙谷二肽的精制方法
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
GB202400295D0 (en) * 2024-01-09 2024-02-21 Stablepharma Ltd Hypertonic thermostable vaccine compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
JPS6013718A (ja) * 1983-07-05 1985-01-24 Chemo Sero Therapeut Res Inst Ｂ型肝炎ワクチン
JP2749449B2 (ja) * 1992-12-28 1998-05-13 ユー、シイ−チャン 不揮発性半導体メモリセル
EP0678035B9 (de) * 1993-01-08 2006-12-13 Csl Limited Impfstoffpräparate
TW404844B (en) * 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
US5902565A (en) * 1993-12-24 1999-05-11 Csl Limited Spray dried vaccine preparation comprising aluminium adsorbed immunogens
RU2096042C1 (ru) * 1996-11-06 1997-11-20 Виктор Иванович Ситьков Способ получения поливалентной вакцины против лептоспироза животных
NZ504894A (en) * 1997-12-02 2002-12-20 Powderject Vaccines Inc Crystalline vaccine and adjuvant compositions jointly and separately administered to animals using a transdermal or transmucosally delivery technique

Also Published As

Publication number Publication date
NZ523103A (en) 2005-08-26
CA2412197A1 (en) 2001-12-13
AU2001275371B9 (en) 2007-06-07
MXPA02012039A (es) 2003-06-06
WO2001093829A3 (en) 2002-06-13
AU2001275371B2 (en) 2006-12-21
CN1438874A (zh) 2003-08-27
NZ552576A (en) 2008-06-30
JP2003535119A (ja) 2003-11-25
BR0111494A (pt) 2004-01-13
EP1289494A2 (de) 2003-03-12
KR20030020294A (ko) 2003-03-08
WO2001093829A2 (en) 2001-12-13
AU7537101A (en) 2001-12-17

Similar Documents

Publication Publication Date Title
IL153241A0 (en) Powder compositions
GB0010227D0 (en) Pouched compositions
GB0010249D0 (en) Pouched compositions
EP1341554A4 (de) Zusammensetzung auf colostrumbasis
GB0011084D0 (en) Cosmetic compositions
GB0016937D0 (en) Antiperspirant compositions
EP1320385A4 (de) Kombinationszusammensetzungen
GB0019651D0 (en) Compositions
GB0022667D0 (en) Pouched compositions
EP1270611A4 (de) Zusammensetzung
GB2376022B (en) Powder coating compositions
GB0025439D0 (en) Cosmetic compositions
GB0016067D0 (en) Oral compositions
EP1269969A4 (de) Kosmetische zusammensetzungen
GB2372518B (en) Powder composition
GB0022297D0 (en) Oral compositions
GB0004518D0 (en) Compositions
AU2001287852A8 (en) Composition
GB2376021B (en) Powder coating compositions
EP1267814A4 (de) Zubereitung
GB0031267D0 (en) Novel compositions
GB0004522D0 (en) Compositions
GB0018526D0 (en) Compositions
GB0001854D0 (en) Compositions
GB0017288D0 (en) Compositions